|
XRN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.748800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.769400E-01 |
| Normal-vs-Stage2 |
4.895400E-01 |
| Normal-vs-Stage3 |
5.285400E-01 |
| Normal-vs-Stage4 |
9.949400E-01 |
| Stage1-vs-Stage2 |
3.900800E-01 |
| Stage1-vs-Stage3 |
6.906400E-01 |
| Stage1-vs-Stage4 |
8.160800E-01 |
| Stage2-vs-Stage3 |
2.958600E-01 |
| Stage2-vs-Stage4 |
5.136400E-01 |
| Stage3-vs-Stage4 |
5.777400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.021800E-01 |
| Normal-vs-AfricanAmerican |
2.046300E-02 |
| Normal-vs-Asian |
5.458200E-02 |
| Caucasian-vs-AfricanAmerican |
6.137400E-03 |
| Caucasian-vs-Asian |
2.016200E-01 |
| AfricanAmerican-vs-Asian |
5.302200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.994400E-01 |
| Normal-vs-Female |
8.099800E-01 |
| Male-vs-Female |
4.958800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.944600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.957800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.979200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.632200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.821000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.945400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.891600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.192200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.220430E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.845360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.390830E-01 |
| Normal-vs-Grade 2 |
6.226000E-01 |
| Normal-vs-Grade 3 |
2.438800E-01 |
| Normal-vs-Grade 4 |
9.790000E-01 |
| Grade 1-vs-Grade 2 |
2.436200E-01 |
| Grade 1-vs-Grade 3 |
4.482400E-02 |
| Grade 1-vs-Grade 4 |
1.847040E-01 |
| Grade 2-vs-Grade 3 |
7.872200E-02 |
| Grade 2-vs-Grade 4 |
7.081600E-01 |
| Grade 3-vs-Grade 4 |
4.159400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.401600E-01 |
| Normal-vs-ccB subtype |
9.755400E-01 |
| ccA subtype-vs-ccB subtype |
2.983800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.224800E-01 |
| Normal-vs-N1 |
4.401400E-01 |
| N0-vs-N1 |
4.472400E-01 |
|
|
